Strategic Partnerships Recent collaboration with Lovell Government Services indicates demand for federal healthcare solutions, presenting an opportunity to pursue broader government contracting channels and veteran health programs.

Clinical Expertise Advisory board appointments of multiple medical and research experts signal strong scientific credibility; target hospital systems and wound care centers seeking evidence-based, botanically derived diabetic wound therapies.

Market Expansion Product launches and Walmart distribution for Diabetic Hydrogel Wound Dressing expand retail and outpatient exposure; leverage these channels to upsell complementary wound care solutions to retailers, clinics, and home care providers.

Financial Targeting Current revenue in the low-to-mid multi-million range with ongoing funding indicates room to scale; approach strategic investors and healthcare distributors to accelerate manufacturing scale and field deployment.

Operational Readiness Small to midsize team size (11-50 employees) combined with FDA-compliant, high-safety formulations suggests a nimble supplier capable of rapid customization; pursue contract manufacturing, private label, and OEM partnerships with medical device distributors.